This website is intended for healthcare professionals only and contains promotional content.
United Kingdom - English
United Kingdom | English
These country specific websites are specifically intended for healthcare professionals in listed countries only.
NOTICE: Kyowa Kirin International has agreed a joint venture with Grünenthal GmbH for the Established Medicines portfolio. The new company, KKI NewCo (known as Grünenthal Meds), is responsible for the content on this page. For more information please click here.
SANCUSO transdermal patch is indicated for the prevention of nausea and vomiting associated with moderately or highly emetogenic multi-day chemotherapy in adult patients with swallowing difficulties.1
Adverse Events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse Events should also be reported to Kyowa Kirin International UK NewCo Ltd, known as Grünenthal Meds on +44 (0)1896 664000, email PVUK@grunenthalmeds.com
Click here for prescribing information.
How does SANCUSO work?
SANCUSO is a transparent, discreet adhesive patch that delivers a steady dose of granisetron via the skin for up to 7 days, used in the prevention of nausea and vomiting associated with chemotherapy treatment.1
Granisetron is a ‘5-HT3 receptor antagonist’, which counteracts the effects of serotonin.1 Serotonin is a natural substance in the body that occurs at higher levels due to chemotherapy treatment, leading to potential nausea and vomiting symptoms.2
1. SANCUSO 3.1 mg/24 hours transdermal patch SPC.
2. Nelly A. Am J Manag Care. 2017;23:S259-S265.
Deutschland
- Deutsch
España
- Español
Italia
- Italiano